Is Well Health Stock a Buy in December 2022?

Well Health is a beaten-down TSX stock that should be on the radar of growth and value-seeking investors right now.

| More on:
investment research

Image source: Getty Images

The current year has been extremely brutal for growth stocks across sectors. The triple whammy of rising inflation, supply chain disruptions, and higher interest rates has dragged valuations of several growth stocks lower in 2022.

But the pullback offers investors the chance to buy quality stocks at a depressed valuation and benefit from outsized gains once the market recovers. One such beaten-down TSX tech stock is WELL Health (TSX:WELL). Down 70% from all-time highs, this Canadian health-tech company is currently valued at a market cap of $623 million. Let’s see if WELL stock is a buy in December 2022.

Well Health is a top TSX growth stock

Despite its market-trailing performance in 2022, WELL Health has created massive wealth for long-term investors. WELL Health went public in April 2016 and has since returned over 2,300% to investors in the last six years.

Deploying an acquisition-based business model, the company has increased sales from $10.6 million in 2018 to $302.3 million in 2021. Better still, Well Health expects to end 2022 with sales of $565 million. Comparatively, its bottom line could improve from an adjusted EBITDA (earnings before interest, tax, depreciation and amortization) loss of $1.2 million in 2018 to an EBITDA profit of $100 million in 2022. WELL Health expects to end 2023 with an annual revenue run rate of $700 million.

WELL Health aims to leverage technology and positively impact health outcomes by empowering health practitioners and their patients. It has successfully created a robust end-to-end healthcare system in Canada. South of the border, it provides omnichannel healthcare services and solutions in specialized markets.

WELL Health emphasized that more than 21,000 practitioners purchase its products or services and its annual run rate for patient interactions stood at 4.7 million. Over 90% of the company’s revenues are of a recurring nature, enabling WELL Health to generate cash flows across market cycles.

What next for WELL stock and investors?

WELL Health is likely to focus on highly accretive acquisitions to gain traction in the rapidly expanding digital health market. It has already acquired 50 companies since inception, enabling the company to grow its sales by 177% annually in the last two years.

WELL Health has built a solid practitioner enablement platform from which it derives predictable revenue. Its powerful network effects are primarily driven by the acquisition of physical as well as digital healthcare assets.

Given Bay Street’s revenue estimates for 2023, WELL stock is priced at less than 1 times sales, which is really cheap for a profitable growth stock. Analysts tracking the company remain bullish on WELL Health and expect shares to rise by almost 200% in the next 12 months.

The Foolish takeaway

WELL Health has multiple secular tailwinds that should allow the company to outpace the broader markets in the upcoming decade. It’s currently on track to report free cash flow of $50 million in the next 12 months, making it one of the most undervalued growth stocks on the TSX right now.

WELL Health’s cheap valuation, widening profit margins, and acquisition-based business model suggest it is a top buy for December 2022.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

top TSX stocks to buy
Tech Stocks

2 Top Stocks That Could Turn $10,000 Into $50,000 by 2030

TSX investors can buy shares of quality growth stocks, such as Snowflake, allowing them to generate exponential gains in 2023…

Read more »

Tech Stocks

Don’t Wait for a Market Bottom: These 2 Stocks Are on Sale

Two of the best Canadian growth stocks could keep soaring in 2023 and beyond.

Read more »

clock time
Tech Stocks

3 Top ‘Future’ Stocks to Hold for the Rest of This Decade

Canadian growth stocks like Constellation Software are starting to look appealing.

Read more »

Credit card, online shopping, retail
Tech Stocks

Nuvei stock: Can This Gainer Keep on Running?

Despite a 40% increase in its stock price, I expect the uptrend in Nuvei to continue, given its higher growth…

Read more »

value for money
Tech Stocks

3 Growth Stocks You Can Buy Now With Less Than $100

Thanks to the recent bear market, you can now buy growth stocks like Shopify at bargain prices.

Read more »

Upwards momentum
Tech Stocks

The 1 Canadian Stock I Think Could Double in 3 Years

Here’s why this top Canadian stock has the potential to double in three years or sooner.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

Why Open Text Stock Rose 11% Last Month

Not all tech stocks are performing poorly. In fact, Open Text stock (TSX:OTEX) continues to rise higher, though it's still…

Read more »

Businessman holding AI cloud
Tech Stocks

2 AI Stocks to Watch in February 2023

Those looking to invest in AI stocks can consider companies such as Nvidia and CrowdStrike Holdings right now.

Read more »